When was Moximed founded?

Moximed was founded in 2006 and raised its 1st funding round 2 years after it was founded.

Where is Moximed located?

Moximed is headquartered in Hayward, United States. It is registered at Fremont, California.

How many employees does Moximed have?

As of Jul 31, 2026, the latest employee count at Moximed is 80.

Is Moximed a funded company?

Moximed is a funded company, having raised a total of $262M across 8 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Jun 2008.

When was the latest funding round of Moximed?

Moximed's latest funding was a $***** Series D round on Aug 07, 2024, with participation from 10 investors. Its primary sector is Orthopedics. In United States, the Orthopedics sector has seen $2.48B in funding in 2026 to date.

Where does Moximed rank among its competitors?

Moximed ranks 5th amongst 22 active competitors, of which 9 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was ATRO Medical, which secured $3.54M in Feb, 2026.

Who are the top competitors of Moximed?

Moximed's top competitors include Hyalex, Allay Therapeutics and ATRO Medical. Among them, ATRO Medical secured the most recent funding round in February, 2026.

Moximed - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of an implant for pre-arthroplasty osteoarthritis patients. The lead product, the KineSpring Knee Implant System, is designed for patients with knee osteoarthritis. It's a partial load absorber that reduces knee joint load by up to 13 kg.

Website: moximed.com
Registered Address: Fremont, California

Key Metrics

Founded Year

2006

Location

Hayward, United States

Stage

Series D

Total Funding

$262M in 8 rounds

Latest Funding Round

Series D, Aug 07, 2024, $*****

Investors

Future Fund & 14 more

Ranked

5^th among 22 active competitors

Employee Count

80 as on Jul 31, 2026

Similar Companies

Hyalex & 23 more

View Moximed's full profile

Moximed is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MOXIMED INC. CIN: 205769994 , United States, Active	Dec 26, 999	-	45 (As on Dec 31, 2024)	-

Moximed has raised a total funding of $262M over 8 rounds. Its first funding round was on Jun 2008. Its latest funding round was a Series D round on Aug 07, 2024 for $*****. 10 investors participated in its latest round. Moximed has 15 institutional investors.

Here is the list of recent funding rounds of Moximed:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 07, 2024	7652147	Series D	3861811	9777031	9853281	3024799
Aug 16, 2022	4261119	Series C	9148487	7227717	6570799	Advent Life Sciences & 5 more
Aug 16, 2022	5002101	Conventional Debt	7746818	9172436	4276674	Runway Growth Capital

Access funding benchmarks and valuations. Sign up today!

View details of Moximed's funding rounds and investors

Moximed's Board of Directors

Moximed's board has 20 active members. Ryan Drant, Joshua Makower, Michael Wasserman, Shahzad Malik, Christopher Shen, Robert W. Croce, Robert K. Anderson, Arthur Franken, James Leech, Kevin K. Sidow, David van Meter, David Amerson, Dan Murray, Anton Clifford, Henry A. Plain, Matt McAviney, John Nehra, Henry A. Plain, Jr., Christopher Gleason and Robert More are independent board members.

Here is the list of Moximed's board of directors:

Name	Type	Representing	Status	Duration
Ryan Drant	Independent board member	-	Current	17y 0m
nzjkazo	Independent board member	-	Current	5y 5m
azajzgg	Independent board member	-	Current	3y 1m
ws{{rhe	Independent board member	-	Current	3y 8m
swpux{k	Independent board member	-	Current	1y 4m
vnvyyrz	Independent board member	-	Current	1y 8m
ehvjtuf	Independent board member	-	Current	9y 2m
qsdqlaz	Independent board member	-	Current	3y 2m
rcxmyhd	Independent board member	-	Current	3y 1m
qmeomze	Independent board member	-	Current	9y 6m
pgprsor	Independent board member	-	Current	6y 3m
kwzifow	Independent board member	-	Current	2y 9m
snbvcxi	Independent board member	-	Current	6y 3m
ntudyig	Independent board member	-	Current	5y 7m
pv{ewbx	Independent board member	-	Current	6y 6m
udlngvc	Independent board member	-	Current	3y 1m
vvuxsxd	Independent board member	-	Current	1y 3m
xirjjyx	Independent board member	-	Current	3y 3m
wxzyjwe	Independent board member	-	Current	9y 8m
mnaenad	Independent board member	-	Current	5y 8m

Moximed's employee count trend

Moximed has 80 employees as of Jul 26. Here is Moximed's employee count trend over the years:

Uncover Moximed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Moximed include Hyalex, Allay Therapeutics and ATRO Medical. Here is the list of Top 10 competitors of Moximed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Hyalex 2016, Lexington (United States), Series A	Developer of a synthetic cartilage platform to restore damaged joint surfaces	$46.4M	Canaan, Strategic Healthcare Investment Partners ... & 5 others	61/100
2nd	Allay Therapeutics 2017, Menlo Park (United States), Series D	Developer of drugs for post-surgical pain management	$159M	Arboretum Ventures, Lightstone Ventures & 15 others	57/100
3rd	ATRO Medical 2016, Nijmegen (Netherlands), Series A	Developer of a polymer-based meniscus implant	$5.68M	Thuja Capital, BOM & 13 others	52/100
4th	CoreTissue BioEngineering 2016, Yokohama (Japan), Series A	Developer of implantable medical devices derived from living tissues	$3.91M	MMA Investment, NextG Investment & 5 others	48/100
5th	Moximed 2006, Hayward (United States), Series D	Developer of an implant for pre-arthroplasty osteoarthritis patients	$262M	Gilde Healthcare, Advent Life Sciences & 13 others	46/100
6th	Biotech Healthcare 1999, Lucerne (Switzerland), Unfunded	Manufacturer of ophthalmic, orthopedic, and aesthetic medical products. The company develops and produces intraocular lenses, viscosupplements, and dermal fillers. Its ophthalmology products support cataract and refractive surgery, while its orthopedics offerings address joint pain and mobility. The aesthetics product line focuses on skin rejuvenation. The company's manufacturing facilities utilize advanced technologies to ensure product quality and efficacy.	-	-	42/100
7th	Sparta Biomedical 2017, Research Triangle Park (United States), Seed	Developing cartilage-like implants to treat osteoarthritis and restore joint function	$5M	Duke University, Nanosha	37/100
8th	JointMedica 2008, United Kingdom, Seed	Provider of smart devices for knee replacement	-	ExacTech, SETsquared	32/100
9th	Optimotion Implants 2016, Orlando (United States), Seed	Developer of knee replacement implants and surgical devices	$2.25M	-	30/100
10th	Hippos Exoskeleton 2024, San Francisco (United States), Seed	Manufacturer of intelligent wearable leggings featuring integrated knee protection systems	$642K	Possible Ventures, Silicon Roundabout Ventures ... & 1 others	24/100